Sun Pharma Enters Definitive Agreement to Acquire Organon Sun Pharmaceutical Industries Limited and Organon & Co. have entered into a definitive agreement that marks one of the most significant consolidation moves in the global pharmaceutical sector in recent years. Under…
WuXi Biologics’ Chengdu Microbial Manufacturing Facility Reaches Structural Completion with Key Equipment Installed WuXi Biologics has reached a major construction milestone in its global manufacturing expansion strategy, announcing the structural completion of its new microbial commercial manufacturing facility in Chengdu,…
Genentech Collaborates with Damon Wayans and diaTribe to Raise Awareness of Diabetes-Related Vision Loss Through ‘All Eyes on DME’ Campaign Genentech, a member of the Roche Group, has introduced a new awareness initiative aimed at addressing one of the most…
Bristol Myers Squibb and Pfizer Partner with Mark Cuban Cost Plus Drug Company to Expand Access to Eliquis® (apixaban) The longstanding alliance between Bristol Myers Squibb and Pfizer has announced a notable expansion of its patient access strategy through a…
Arrowhead Pharmaceuticals Secures Positive CHMP Recommendation for REDEMPLO® (plozasiran) to Treat Elevated Triglycerides in Adults with Familial Chylomicronemia Syndrome in Europe Arrowhead Pharmaceuticals has taken a significant step forward in advancing treatment options for patients living with the rare and…
BNB Plus Corp. Finalizes Landmark $1.2 Million LineaDNA™ Order BNB Plus Corp. has announced a significant operational milestone through its biopharmaceutical subsidiary, LineaRx, Inc., which has successfully completed the largest commercial order in its history. The achievement not only highlights…
AbbVie Chooses North Carolina as Site for $1.4 Billion Advanced Manufacturing Facility AbbVie has unveiled an ambitious new chapter in its long-term growth strategy with the announcement of a $1.4 billion investment to establish a cutting-edge pharmaceutical manufacturing campus in…
Kallyope Presents Phase 2b Data on Elismetrep, a Novel Migraine Therapy, at the American Academy of Neurology Annual Meeting Kallyope, a late-stage biopharmaceutical company focused on developing innovative treatments for neurological and metabolic disorders, has announced promising results from a…
Veristat to Acquire Certara’s Regulatory Affairs and Medical Writing Business Veristat, a science-first, full-service clinical research organization (CRO) and consultancy specializing in advancing complex therapies from early development through regulatory submission, has announced its intended acquisition of Certara’s Regulatory and…
Pfizer Highlights Oncology Innovation and Advances in Next-Generation Pipeline at ASCO 2026 Pfizer Inc. (NYSE: PFE) has announced an extensive and data-rich presence at the American Society of Clinical Oncology Annual Meeting 2026, scheduled to take place from May 29…
Genentech’s Enspryng (Satralizumab) Cuts Relapse Risk by 68%, Showing Promise as a Potential First Treatment for MOGAD Genentech, a member of the Roche Group, has announced compelling new results from its Phase III METEOROID clinical trial evaluating Enspryng (satralizumab) in…
n-Lorem Foundation Reaches Key Milestone with 50th Nano-Rare Patient Treated Using a Personalized Antisense Oligonucleotide Therapy n-Lorem, a nonprofit foundation dedicated to advancing precision genetic medicine for individuals with ultra-rare conditions, has reached a significant milestone with the treatment of…